Logo image of AHCO

ADAPTHEALTH CORP (AHCO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AHCO - US00653Q1022 - Common Stock

10.64 USD
+0.1 (+0.95%)
Last: 1/15/2026, 8:00:00 PM
10.64 USD
0 (0%)
After Hours: 1/15/2026, 8:00:00 PM
Fundamental Rating

4

Taking everything into account, AHCO scores 4 out of 10 in our fundamental rating. AHCO was compared to 100 industry peers in the Health Care Providers & Services industry. While AHCO is still in line with the averages on profitability rating, there are concerns on its financial health. AHCO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year AHCO was profitable.
  • In the past year AHCO had a positive cash flow from operations.
  • In multiple years AHCO reported negative net income over the last 5 years.
  • AHCO had a positive operating cash flow in each of the past 5 years.
AHCO Yearly Net Income VS EBIT VS OCF VS FCFAHCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

  • AHCO's Return On Assets of 1.69% is in line compared to the rest of the industry. AHCO outperforms 55.00% of its industry peers.
  • AHCO has a Return On Equity (4.83%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 4.53%, AHCO is in line with its industry, outperforming 53.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AHCO is below the industry average of 9.19%.
  • The 3 year average ROIC (4.25%) for AHCO is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.69%
ROE 4.83%
ROIC 4.53%
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
AHCO Yearly ROA, ROE, ROICAHCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • AHCO has a Profit Margin of 2.33%. This is in the better half of the industry: AHCO outperforms 63.00% of its industry peers.
  • In the last couple of years the Profit Margin of AHCO has declined.
  • AHCO has a Operating Margin of 7.82%. This is in the better half of the industry: AHCO outperforms 74.00% of its industry peers.
  • AHCO's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 25.32%, AHCO is in line with its industry, outperforming 53.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AHCO has grown nicely.
Industry RankSector Rank
OM 7.82%
PM (TTM) 2.33%
GM 25.32%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
AHCO Yearly Profit, Operating, Gross MarginsAHCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AHCO is destroying value.
  • AHCO has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AHCO has been increased compared to 5 years ago.
  • Compared to 1 year ago, AHCO has an improved debt to assets ratio.
AHCO Yearly Shares OutstandingAHCO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AHCO Yearly Total Debt VS Total AssetsAHCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of 1.08, we must say that AHCO is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.08, AHCO is not doing good in the industry: 71.00% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of AHCO is 9.48, which is on the high side as it means it would take AHCO, 9.48 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AHCO (9.48) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.27 is on the high side and indicates that AHCO has dependencies on debt financing.
  • AHCO's Debt to Equity ratio of 1.27 is on the low side compared to the rest of the industry. AHCO is outperformed by 64.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 9.48
Altman-Z 1.08
ROIC/WACC0.57
WACC8%
AHCO Yearly LT Debt VS Equity VS FCFAHCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • AHCO has a Current Ratio of 1.33. This is a normal value and indicates that AHCO is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of AHCO (1.33) is comparable to the rest of the industry.
  • AHCO has a Quick Ratio of 1.09. This is a normal value and indicates that AHCO is financially healthy and should not expect problems in meeting its short term obligations.
  • AHCO's Quick ratio of 1.09 is in line compared to the rest of the industry. AHCO outperforms 43.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.09
AHCO Yearly Current Assets VS Current LiabilitesAHCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 119.39% over the past year.
  • Measured over the past years, AHCO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.23% on average per year.
  • Looking at the last year, AHCO shows a very negative growth in Revenue. The Revenue has decreased by -19.72% in the last year.
  • Measured over the past years, AHCO shows a very strong growth in Revenue. The Revenue has been growing by 43.84% on average per year.
EPS 1Y (TTM)119.39%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)-19.72%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%1.79%

3.2 Future

  • AHCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.59% yearly.
  • Based on estimates for the next years, AHCO will show a small growth in Revenue. The Revenue will grow by 7.27% on average per year.
EPS Next Y19.85%
EPS Next 2Y31.12%
EPS Next 3Y26.83%
EPS Next 5Y20.59%
Revenue Next Year-0.06%
Revenue Next 2Y3.16%
Revenue Next 3Y4.99%
Revenue Next 5Y7.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AHCO Yearly Revenue VS EstimatesAHCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
AHCO Yearly EPS VS EstimatesAHCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

6

4. Valuation

4.1 Price/Earnings Ratio

  • AHCO is valuated quite expensively with a Price/Earnings ratio of 33.25.
  • AHCO's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of AHCO to the average of the S&P500 Index (27.54), we can say AHCO is valued slightly more expensively.
  • The Price/Forward Earnings ratio is 10.32, which indicates a very decent valuation of AHCO.
  • Based on the Price/Forward Earnings ratio, AHCO is valued cheaper than 90.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of AHCO to the average of the S&P500 Index (24.31), we can say AHCO is valued rather cheaply.
Industry RankSector Rank
PE 33.25
Fwd PE 10.32
AHCO Price Earnings VS Forward Price EarningsAHCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AHCO is valued cheaply inside the industry as 93.00% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, AHCO is valued cheaper than 92.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.76
EV/EBITDA 5.32
AHCO Per share dataAHCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • AHCO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AHCO's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.68
PEG (5Y)N/A
EPS Next 2Y31.12%
EPS Next 3Y26.83%

0

5. Dividend

5.1 Amount

  • AHCO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ADAPTHEALTH CORP

NASDAQ:AHCO (1/15/2026, 8:00:00 PM)

After market: 10.64 0 (0%)

10.64

+0.1 (+0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-23
Inst Owners93.73%
Inst Owner Change0.04%
Ins Owners1.81%
Ins Owner Change-0.06%
Market Cap1.44B
Revenue(TTM)3.26B
Net Income(TTM)75.81M
Analysts81.43
Price Target13.52 (27.07%)
Short Float %8.81%
Short Ratio8.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-123.07%
Min EPS beat(2)-210.83%
Max EPS beat(2)-35.31%
EPS beat(4)1
Avg EPS beat(4)-384.03%
Min EPS beat(4)-1325.49%
Max EPS beat(4)35.5%
EPS beat(8)1
Avg EPS beat(8)-358.04%
EPS beat(12)3
Avg EPS beat(12)-235.24%
EPS beat(16)3
Avg EPS beat(16)-191.39%
Revenue beat(2)1
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.19%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.28%
Revenue beat(8)4
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0%
PT rev (3m)0.95%
EPS NQ rev (1m)-4.44%
EPS NQ rev (3m)-14%
EPS NY rev (1m)-3.42%
EPS NY rev (3m)-11.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 33.25
Fwd PE 10.32
P/S 0.44
P/FCF 6.76
P/OCF 2.53
P/B 0.92
P/tB N/A
EV/EBITDA 5.32
EPS(TTM)0.32
EY3.01%
EPS(NY)1.03
Fwd EY9.69%
FCF(TTM)1.57
FCFY14.79%
OCF(TTM)4.2
OCFY39.49%
SpS24.04
BVpS11.6
TBVpS-8.93
PEG (NY)1.68
PEG (5Y)N/A
Graham Number9.14
Profitability
Industry RankSector Rank
ROA 1.69%
ROE 4.83%
ROCE 6.5%
ROIC 4.53%
ROICexc 4.66%
ROICexgc 17.24%
OM 7.82%
PM (TTM) 2.33%
GM 25.32%
FCFM 6.55%
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
ROICexc(3y)4.34%
ROICexc(5y)3.9%
ROICexgc(3y)17.05%
ROICexgc(5y)18.83%
ROCE(3y)6.1%
ROCE(5y)5.39%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y-13.24%
ROICexc growth 3Y18.04%
ROICexc growth 5Y-2.96%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
F-Score7
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 9.48
Debt/EBITDA 3.16
Cap/Depr 94.9%
Cap/Sales 10.93%
Interest Coverage 2.41
Cash Conversion 90.37%
Profit Quality 281.18%
Current Ratio 1.33
Quick Ratio 1.09
Altman-Z 1.08
F-Score7
WACC8%
ROIC/WACC0.57
Cap/Depr(3y)94.46%
Cap/Depr(5y)82.09%
Cap/Sales(3y)11.04%
Cap/Sales(5y)9.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.39%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%6.67%
EPS Next Y19.85%
EPS Next 2Y31.12%
EPS Next 3Y26.83%
EPS Next 5Y20.59%
Revenue 1Y (TTM)-19.72%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%1.79%
Revenue Next Year-0.06%
Revenue Next 2Y3.16%
Revenue Next 3Y4.99%
Revenue Next 5Y7.27%
EBIT growth 1Y-29.64%
EBIT growth 3Y12.08%
EBIT growth 5Y59.71%
EBIT Next Year166.06%
EBIT Next 3Y46.84%
EBIT Next 5YN/A
FCF growth 1Y594.38%
FCF growth 3Y48.23%
FCF growth 5Y43.24%
OCF growth 1Y34.71%
OCF growth 3Y25.26%
OCF growth 5Y55.08%

ADAPTHEALTH CORP / AHCO FAQ

What is the ChartMill fundamental rating of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AHCO.


What is the valuation status of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a valuation rating of 6 / 10 to ADAPTHEALTH CORP (AHCO). This can be considered as Fairly Valued.


How profitable is ADAPTHEALTH CORP (AHCO) stock?

ADAPTHEALTH CORP (AHCO) has a profitability rating of 5 / 10.


What is the valuation of ADAPTHEALTH CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ADAPTHEALTH CORP (AHCO) is 33.25 and the Price/Book (PB) ratio is 0.92.